Literature DB >> 32516599

Cell Death in the Origin and Treatment of Cancer.

Andreas Strasser1, David L Vaux2.   

Abstract

Cell death, or, more specifically, cell suicide, is a process of fundamental importance to human health. Throughout our lives, over a million cells are produced every second. When organismal growth has stopped, to balance cell division, a similar number of cells must be removed. This is achieved by activation of molecular mechanisms that have evolved so that cells can destroy themselves. The first clues regarding the nature of one of these mechanisms came from studying genes associated with cancer, in particular the gene for BCL-2. Subsequent studies revealed that mutations or other defects that inhibit cell death allow cells to accumulate, prevent removal of cells with damaged DNA, and increase the resistance of malignant cells to chemotherapy. Knowledge of this mechanism has allowed development of drugs that kill cancer cells by directly activating the cell death machinery and by synergizing with conventional chemotherapy as well as targeted agents to achieve improved outcomes for cancer patients. Crown
Copyright © 2020. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32516599     DOI: 10.1016/j.molcel.2020.05.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  46 in total

1.  [Melatonin inhibits growth and metastasis of MDA-MB-231 breast cancer cells by activating autophagy].

Authors:  D Wu; Y Zhang; H Tang; J Yang; M Li; H Liu; Q Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-02-20

Review 2.  Predictive validity in drug discovery: what it is, why it matters and how to improve it.

Authors:  Jack W Scannell; James Bosley; John A Hickman; Gerard R Dawson; Hubert Truebel; Guilherme S Ferreira; Duncan Richards; J Mark Treherne
Journal:  Nat Rev Drug Discov       Date:  2022-10-04       Impact factor: 112.288

3.  A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.

Authors:  Zilong Bian; Rong Fan; Lingmin Xie
Journal:  Genes (Basel)       Date:  2022-05-10       Impact factor: 4.141

Review 4.  A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer.

Authors:  Franklyn De Silva; Jane Alcorn
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

Review 5.  The role of PFKFB3 in maintaining colorectal cancer cell proliferation and stemness.

Authors:  Siyuan Yan; Qianqian Li; Shi Li; Zhiying Ai; Dongdong Yuan
Journal:  Mol Biol Rep       Date:  2022-05-12       Impact factor: 2.742

6.  BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma.

Authors:  Nenad Sejic; Lindsay C George; Rosemary J Tierney; Catherine Chang; Olga Kondrashova; Ruth N MacKinnon; Ping Lan; Andrew I Bell; Guillaume Lessene; Heather M Long; Andreas Strasser; Claire Shannon-Lowe; Gemma L Kelly
Journal:  Blood Adv       Date:  2020-10-13

7.  Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.

Authors:  Rachel Thijssen; Sarah T Diepstraten; Donia Moujalled; Edward Chew; Christoffer Flensburg; Melissa X Shi; Michael A Dengler; Veronique Litalien; Sarah MacRaild; Maoshan Chen; Natasha S Anstee; Boris Reljić; Sarah S Gabriel; Tirta M Djajawi; Chris D Riffkin; Brandon J Aubrey; Catherine Chang; Lin Tai; Zhen Xu; Thomas Morley; Giovanna Pomilio; Claudia Bruedigam; Axel Kallies; David A Stroud; Ashish Bajel; Ruth M Kluck; Steven W Lane; Marie Schoumacher; Sébastien Banquet; Ian J Majewski; Andreas Strasser; Andrew W Roberts; David C S Huang; Fiona C Brown; Gemma L Kelly; Andrew H Wei
Journal:  Blood       Date:  2021-05-20       Impact factor: 22.113

Review 8.  Cell death pathways: intricate connections and disease implications.

Authors:  Matthias Kist; Domagoj Vucic
Journal:  EMBO J       Date:  2021-01-13       Impact factor: 11.598

9.  Anticancer effect of sodium metavanadate on murine breast cancer both in vitro and in vivo.

Authors:  Yu Tian; Haihui Qi; Gang Wang; Li Li; Dinglun Zhou
Journal:  Biometals       Date:  2021-03-10       Impact factor: 2.949

Review 10.  Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer.

Authors:  Tasia Bos; J Alex Ratti; Hisashi Harada
Journal:  Front Oral Health       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.